FORFIRINOX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FORFIRINOX, covering 2018-12-07 to 2018-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]